ATE163676T1 - Molekulare klone von hiv-1 und deren verwendung - Google Patents
Molekulare klone von hiv-1 und deren verwendungInfo
- Publication number
- ATE163676T1 ATE163676T1 AT91920794T AT91920794T ATE163676T1 AT E163676 T1 ATE163676 T1 AT E163676T1 AT 91920794 T AT91920794 T AT 91920794T AT 91920794 T AT91920794 T AT 91920794T AT E163676 T1 ATE163676 T1 AT E163676T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- present
- relates
- dna segments
- molecular clones
- Prior art date
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 3
- 101710091045 Envelope protein Proteins 0.000 abstract 2
- 101710188315 Protein X Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 238000004166 bioassay Methods 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59949190A | 1990-10-17 | 1990-10-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE163676T1 true ATE163676T1 (de) | 1998-03-15 |
Family
ID=24399839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91920794T ATE163676T1 (de) | 1990-10-17 | 1991-10-17 | Molekulare klone von hiv-1 und deren verwendung |
Country Status (10)
Country | Link |
---|---|
US (3) | US5420030A (de) |
EP (1) | EP0554389B2 (de) |
JP (1) | JP2767078B2 (de) |
AT (1) | ATE163676T1 (de) |
AU (1) | AU649502B2 (de) |
CA (1) | CA2093427C (de) |
DE (1) | DE69129034T3 (de) |
DK (1) | DK0554389T4 (de) |
ES (1) | ES2115622T5 (de) |
WO (1) | WO1992006990A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341482C (en) * | 1984-10-31 | 2005-05-10 | Paul A. Luciw | Process for preparing fragments of aids-associated retroviruses |
DE4228787A1 (de) * | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
ATE174382T1 (de) * | 1992-10-06 | 1998-12-15 | Dade Behring Marburg Gmbh | Retrovirus aus der hiv-gruppe und dessen verwendung |
AU700371B2 (en) * | 1993-06-07 | 1999-01-07 | Genentech Inc. | Hiv envelope polypeptides |
ES2196018T3 (es) * | 1993-08-11 | 2003-12-16 | Wyeth Corp | Vacunas de adenovirus recombinantes. |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6585979B1 (en) * | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
FR2756843B1 (fr) | 1996-12-09 | 1999-01-22 | Inst Nat Sante Rech Med | Souches de vih-1 non-m non-o, fragments et applications |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
US6322976B1 (en) * | 1998-05-28 | 2001-11-27 | Medical Research Council | Compositions and methods of disease diagnosis and therapy |
US7311920B1 (en) | 1999-10-08 | 2007-12-25 | University Of Maryland Biotechnology Institute | Virus coat protein/receptor chimeras and methods of use |
US6908612B2 (en) | 1999-10-08 | 2005-06-21 | University Of Maryland Biotechnology Institute | Virus coat protein/receptor chimeras and methods of use |
CA2835978C (en) | 2000-09-01 | 2016-10-11 | Gen-Probe Incorporated | Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
US6582920B2 (en) | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
WO2004045495A2 (en) * | 2002-05-10 | 2004-06-03 | The Henry M. Jackson Foundation | Interacting site for gp41 on gp120 of hiv-1 |
CA2505583C (en) * | 2002-12-03 | 2014-07-15 | University Of Massachusetts | Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
JP4038679B2 (ja) * | 2003-05-13 | 2008-01-30 | 住友電気工業株式会社 | 半導体レーザーバーの固定用治具 |
EP1625144A4 (de) * | 2003-05-19 | 2007-09-12 | Univ Duke | Polyvalentes immunogen |
WO2008115427A2 (en) * | 2007-03-16 | 2008-09-25 | 454 Life Sciences Corporation | System and method for detection of hiv drug resistant variants |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6226300A (ja) * | 1984-10-10 | 1987-02-04 | セントコ−・インコ−ポレ−テツド | Htlv−3dnaのクロ−ニングおよび発現 |
US5820865A (en) * | 1988-01-26 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
WO1990014427A2 (en) * | 1989-05-25 | 1990-11-29 | Sandoz Ltd | Multivalent repressor of gene function |
JPH05507559A (ja) * | 1990-06-08 | 1993-10-28 | レプリジェン、コーポレーション | 抗hiv―1抗体に関するイムノアッセイ |
-
1991
- 1991-10-17 DE DE69129034T patent/DE69129034T3/de not_active Expired - Lifetime
- 1991-10-17 DK DK91920794T patent/DK0554389T4/da active
- 1991-10-17 WO PCT/US1991/007611 patent/WO1992006990A1/en active IP Right Grant
- 1991-10-17 JP JP3518591A patent/JP2767078B2/ja not_active Expired - Lifetime
- 1991-10-17 AU AU89363/91A patent/AU649502B2/en not_active Expired
- 1991-10-17 EP EP91920794A patent/EP0554389B2/de not_active Expired - Lifetime
- 1991-10-17 CA CA002093427A patent/CA2093427C/en not_active Expired - Lifetime
- 1991-10-17 AT AT91920794T patent/ATE163676T1/de not_active IP Right Cessation
- 1991-10-17 ES ES91920794T patent/ES2115622T5/es not_active Expired - Lifetime
-
1993
- 1993-02-25 US US08/022,835 patent/US5420030A/en not_active Expired - Lifetime
-
1995
- 1995-02-15 US US08/388,809 patent/US5576000A/en not_active Expired - Lifetime
-
1996
- 1996-05-14 US US08/647,714 patent/US5869313A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69129034T2 (de) | 1998-10-08 |
EP0554389A1 (de) | 1993-08-11 |
EP0554389B1 (de) | 1998-03-04 |
DE69129034T3 (de) | 2003-05-08 |
EP0554389B2 (de) | 2002-08-14 |
US5869313A (en) | 1999-02-09 |
AU8936391A (en) | 1992-05-20 |
WO1992006990A1 (en) | 1992-04-30 |
US5420030A (en) | 1995-05-30 |
ES2115622T5 (es) | 2003-03-16 |
DK0554389T3 (da) | 1998-12-07 |
CA2093427A1 (en) | 1992-04-18 |
DE69129034D1 (de) | 1998-04-09 |
JPH05507205A (ja) | 1993-10-21 |
DK0554389T4 (da) | 2002-11-11 |
CA2093427C (en) | 2008-01-15 |
US5576000A (en) | 1996-11-19 |
ES2115622T3 (es) | 1998-07-01 |
EP0554389A4 (en) | 1994-07-06 |
JP2767078B2 (ja) | 1998-06-18 |
AU649502B2 (en) | 1994-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE163676T1 (de) | Molekulare klone von hiv-1 und deren verwendung | |
Bryan | Vinblastine and microtubules: II. Characterization of two protein subunits from the isolated crystals | |
BR7908410A (pt) | Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos | |
Wagner et al. | Structural proteins of vesicular stomatitis viruses | |
ATE294864T1 (de) | Äusseres membranprotein von haemophilus | |
ATE90384T1 (de) | Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder ''acquired immune deficiency syndrome'' (aids). | |
KR950032279A (ko) | 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna) | |
ATE110782T1 (de) | Rekombinanter menschlicher endothelzellenwachstumsfaktor. | |
DE69737125D1 (de) | Streptococcus pneumoniae antigene und impfstoffe | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
SE8703225L (sv) | Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner | |
FI861485A (fi) | Producering av immunologiskt reaktiva virala proteiner. | |
ATE122394T1 (de) | Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung. | |
FR2660757B1 (fr) | Procede d'identification ou de dosage de proteines et applications. | |
DE60125537D1 (de) | Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen | |
ATE191568T1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
Murphy et al. | Purification of an endogenous pyrogen, with an appendix on assay methods | |
ATE109158T1 (de) | Rubella-e1 und c peptide. | |
ATE352623T1 (de) | Impstoffe gegen coccidiosis | |
AU4981093A (en) | Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof | |
DE60035485D1 (de) | IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407 | |
FI885025A (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. | |
Yakobson et al. | Monkey interferon: activity on human cells and chromatographic properties | |
ATE380882T1 (de) | Vektorsystem zum screening von wirkstoffen | |
KR950000879A (ko) | 신규한 인간 면역결핍 바이러스-2(hiv-2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0554389 Country of ref document: EP |
|
EELA | Cancelled due to lapse of time |